author-photo

Noel Estrada-Merly

Center for International Blood and Marrow Transplant Research

13

Papers

6

Citations

Citation Trend

Filter By

Papers (13) Sort By

Journal Conference Others

A second autologous hematopoietic cell transplantation is a safe and effective salvage therapy in select relapsed or refractory AL amyloidosis patients.

2021 Bone Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (0)
Haploidentical vs. sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia.

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (0)
Title: Impact of Induction Therapy with VRD vs. VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell Transplantation

2021
Show All
- Source
- Cite
- Save
Citations (0)
Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis.

2021 Bone Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (0)
Improved outcomes with maintenance therapy after salvage autologous hematopoietic cell transplantation (AHCT) in multiple myeloma: A CIBMTR study.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy and Long-Term Outcomes of Autologous Stem Cell Transplant (ASCT) for Patients with POEMS Syndrome (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes): A CIBMTR Analysis

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
The Impact of Somatic Mutations on Allogeneic Hematopoietic Cell Transplantation in Chronic Myelomonocytic Leukemia: A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Maintenance Use Is More Important Than the Choice of Bortezomib-Based Triplet Induction in Newly Diagnosed Multiple Myeloma Patients Undergoing Upfront Autologous Stem Cell Transplantation

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Bortezomib induction prior to autologous hematopoietic cell transplantation (AHCT) for newly diagnosed light chain amyloidosis (AL): A study of 426 patients.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Allogeneic Hematopoietic Cell Transplantation (allo-HCT) in T-Cell Prolymphocytic Leukemia (T-PLL): An Analysis from the CIBMTR

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)